-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

BIOMARIN PHARM Add to My Watchlist

(NSDQ: BMRN)

Detailed Quote

Last Price	16.97 (11.20.09 5:20 PM EST)
Change (%)	-0.37 (-2.13%)
Volume	721,377
Open	17.25
Previous Close	17.34
Day's Range	17.25 - 16.92
Bid / Ask	16.93 / 16.95

Intraday

3 Month

6 Month

1 Year

Average Volume	1,406,460	Shares Outstanding	100.73M
52-Week Range	9.93 - 21.23	Market Cap	1.7B
P/E Ratio	99.8	Earnings Per Share	0.17
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
IDXX	50.73	-0.77 (-1.50%)
SEPR	22.98	+0.00 (+0.00)
TECH	67.12	-0.26 (-0.39%)
UTHR	44.91	+0.10 (+0.22%)
0H1Z	14.94	-0.73 (-4.69%)

Thu, Oct 29, 2009
	BioMarin, Human Genome lead drug stocks higher Drug stocks edged higher in early trading with shares of biotech groups BioMarin Pharmaceutical Inc. and Human Genome Sciences leading the pack. - MarketWatch
Mon, Oct 19, 2009
	Drug stocks split; Amgen falls on FDA delay Drug stocks are split in early action Monday, as shares of Amgen fall on news that the FDA has declined to approve its new osteoporosis drug denosumab, or Prolia, until the company provides more information. - MarketWatch
Wed, Apr 15, 2009
	Dendreon Hits The Big Time (DNDN) Despite positive Phase 3 results, this medicine-maker's valuation is excessive and its new drug won't make it to market for a year. - Investopedia
Fri, Jun 20, 2008
	Five Companies That Love (Earnings) Surprises (BMRN) Stocks that can string together many quarters of positive earnings surprises are usually rewarded. Learn why the market loves a surprise. - Investopedia
More Featured Content

Mon, Nov 16, 2009
	RidgewaterEquity.com Free Fundamental Sector & Market Research on NITE, TIBX, CTIC, KLAC, BMRN and ETFC NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Ridgewater Equity (RWE). - Marketwire
Fri, Nov 13, 2009
	Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme - PR Newswire
Thu, Nov 05, 2009
	United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food - PR Newswire
	Financial & Company Analysis on CPST, ERIC, CVBF, BMRN, HLIT and CDNS from TheFortuneFinancial.com NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com. - Marketwire
Wed, Nov 04, 2009
	BioMarin to Present at the Credit Suisse Healthcare Conference - PR Newswire
More Press Releases

10/28/09		Q3 2009 Earnings Archive for BMRN
07/30/09		Q2 2009 Earnings Archive for BMRN
04/30/09		Q1 2009 Earnings Archive for BMRN
04/01/09		Special Conference 4th Annual Citi Biotech Day Archive for BMRN
03/17/09		Special Conference Cowen and Company Healthcare Conference Archive for BMRN

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs